EXACT Therapeutics AS Logo

EXACT Therapeutics AS

EXTX | XOSL

Overview

Corporate Details

ISIN(s):
NO0010852205 (+1 more)
LEI:
2138006ZE5JAL39AGD55
Country:
Norway
Address:
Østre Aker vei 19, 0581 Oslo
Sector:
Health Care
Industry:
Biotechnology

Description

We are EXACT Therapeutics AS (“EXACT-Tx”), a clinical-stage biopharmaceutical company developing a novel ultrasound-mediated technology platform for targeted therapeutic enhancement – Acoustic Cluster Therapy (ACT®). ACT® is a unique approach to significantly amplify the clinical utility of a wide range of therapeutic agents across a multitude of indications including within oncology (chemotherapy and immunotherapy), infectious diseases, and neurological conditions. EXACT Therapeutics and our ACT® platform builds on decades of R&D efforts within ultrasound and microbubbles performed by the former world leading diagnostic company; Nycomed Imaging AS (now GE Healthcare). In the late 1990’s and early 2000’s the core technology behind ACT® was developed, with more than $10 M and 40 man-years invested into establishing formulation, manufacturing line, quality control etc.

Social Media

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-06-04 09:20
Declaration of Voting Results & Voting Rights Announcements
EXACT Therapeutics AS – Information regarding voting at the Annual General Meet…
English 1.7 KB
2025-05-28 14:53
General Meeting Notice
EXACT Therapeutics AS - Notice of Annual General Meeting 2025 - Attachment: AGM…
Norwegian 1.1 MB
2025-05-28 14:53
General Meeting Notice
EXACT Therapeutics AS - Notice of Annual General Meeting 2025
English 1.4 KB
2025-05-20 06:30
Earnings Release
EXACT Therapeutics announces positive final results in Phase 1 ACTIVATE trial i…
English 115.9 KB
2025-05-20 06:30
Earnings Release
EXACT Therapeutics announces positive final results in Phase 1 ACTIVATE trial i…
English 6.5 KB
2025-05-14 06:35
Regulatory News Service
EXACT Therapeutics announces grant of key patent covering non-invasive delivery…
English 2.1 KB
2025-05-07 08:47
Regulatory News Service
EXACT Therapeutics announces grant of key patent in Japan
English 1.9 KB
2025-04-09 19:17
Annual Report
EXACT Therapeutics - 2024 Annual Report
English 4.9 MB
2025-04-09 19:17
Annual Report
EXACT Therapeutics - 2024 Annual Report
English 1.6 KB
2025-01-28 07:00
Earnings Release
EXACT Therapeutics and Cordance Medical Announce Early Encouraging Data in Brai…
English 3.3 KB
2024-10-08 08:04
Regulatory News Service
EXACT Therapeutics initiates preclinical immunotherapy collaboration with Agenu…
English 4.2 KB
2024-10-02 06:30
Regulatory News Service
EXACT Therapeutics to Present at the bi-annual Contrast Media Research (CMR) Sy…
English 3.2 KB
2024-09-30 06:00
Regulatory News Service
EXACT Therapeutics announces first half 2024 interim results
English 547.1 KB
2024-09-30 06:00
Earnings Release
EXACT Therapeutics announces first half 2024 interim results
English 2.8 KB
2024-09-25 07:00
Regulatory News Service
EXACT Therapeutics announces grant of immunotherapy patent
English 107.3 KB

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo 1NKEMIA Spain IKM
2cureX AB Logo 2cureX AB Sweden 2CUREX
4SC AG Logo 4SC AG Germany VSC
Abera Bioscience AB Logo Abera Bioscience AB Sweden ABERA
ABIONYX Pharma Logo ABIONYX Pharma France ABNX
Abliva Logo Abliva Sweden ABLI
AB Science Logo AB Science France AB
Acticor Biotech Logo Acticor Biotech France ALACT
Active Biotech Logo Active Biotech Sweden ACTI
AcuCort AB Logo AcuCort AB Sweden ACUC